- Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions.
- Genome-wide cell-free DNA fragmentation in patients with cancer.
- Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
- Triage for selection to colonoscopy?
- Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer.
- Direct detection of early-stage cancers using circulating tumor DNA.
- Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects.
- Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer.
- Serological biomarkers in triage of FIT-positive subjects?
- Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
